CATEGORY

Injectors

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Injectors .

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Injectors Market Monitoring Dashboard


Supply Demand

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Injectors Industry Benchmarks


Savings Achieved

(in %)

The average annual savings achieved in Injectors category is 5.15%

Payment Terms

(in days)

The industry average payment terms in Injectors category for the current quarter is 54.3 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length

SLAs/KPIs

Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk

Sanctions

AMEs

Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Injectors Suppliers


    9,777
    Total Suppliers
    154
    Diverse Suppliers
    68
    Normalized Supplier Rating
    Injectors  Supplier

    Find the right-fit injectors supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Company
    IQVIA HOLDINGS INC.
    Location
    Jackson, Mississipi
    Duns number
    3862211

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    4
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance
    36

    100
    Limited (1)
    ESG Perfomance (/100)
    Environment
    41
    Social
    30
    Governance
    43
    6 Domains Performance (/100)
    Business behaviour
    48
    Human rights
    39
    Community Environment
    31
    Corporate governance
    40
    Human resources
    22
    Security Scorecard
    77

    Threat indicators
    C
    75
    Network Security
    Detecting insecure network settings
    A
    100
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    D
    63
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    C
    70
    Application Security
    Detecting common website application vulnerbilities
    C
    77
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    A
    100
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    D
    60
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    A
    100
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    A
    100
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    A
    100
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    iqvia.com
    Industry average
    Adverse Media Appearances
    Environmental Issues
    0
    Workforce Health Safety Issues
    0
    Product Service Issues
    1
    Human Rights Issues
    0
    Production Supply Chain Issues
    0
    Environmental Non Compliance Flags
    1
    Corruption Issues
    0
    Regulatory Non Compliance Flags
    2
    Fraud Issues
    0
    Labor Health Safety Flags
    0
    Regulatory Issues
    2
    Workforce Disputes
    0
    Sanctions
    0
    esg energy transition
    28
    Discrimination Workforce Rights Issues
    0
    esg controversies critical severity
    No

    Injectors Market Intelligence

    global market outlook

      • The global self-injecting device market was valued at ~$43.1 billion in 2020 and is expected to reach $152.63 billion by 2026 at a CAGR of ~23.4 percent..
      • Growth is being driven by new drugs introduced in the market requiring delivery by injection (~40 percent of drugs under development are expected to be delivered parenterally requiring some form of injector), increase in incidence of chronic diseases like diabetes, new product development, among others.
      • There is a growing need for injection devices especially for home use which can increase the quality of life for patients.
      • In the US, due to increase in diabetes population, there is a huge demand for autoinjectors. Additionally, rising awareness for home healthcare settings boosts the demand for technologically advanced autoinjectors, which drives the price of the product.
      • The global injectors market is fragmented, and the key players are Flex, Jabil, Elcam Medical, Cambridge Consultants Inc and Oval Medical Technologies.

    Injectors market report transcript


    Injectors Global Market Outlook:

    MARKET OVERVIEW Global market size – $4.76 billion (2019)
    Expected to grow at a CAGR of 13.4 percent to $11.47 billion by 2025

    Market Trends:
    The ability of self-administration of drugs or medicines is a key factor fueling demand for pen injectors. The devices offer advantages such as fewer visits to hospitals or clinics, low cost, and ease of use. Extensive research and development activities by key players to develop self-injection products and rise in approvals of novel self-injection devices.

    Porter's Analysis on Injectors

    Supplier Power

    • The supplier market for injectors has established players, with global presence. The market is value based as the devices are expensive
    • Moreover, generic players are entering the market to reduce the monopoly
    • Hence, the supplier power varies from medium to high

    Barriers to New Entrants

    • Huge medical, R&D expertise, capital requirements makes it difficult for new entrants
    • Huge competition and majority of the companies profits depends on volume of sales
    • Meeting global regulatory requirements a key challenge for medium to complex medical
    • Need to have a good distribution network to offer better products and after sales services
    • Presence of established players in the market

    Intensity of Rivalry

    • Existing competition is strong among the top players viz. Ypsomed, BD, etc.
    • Continuous innovation in the market coupled with huge demand for injectors leave the intensity of the rivalry as high among suppliers

    Threat of Substitutes

    • Traditional injections, pre filled syringes, an other type of injectors are economical alternatives to self injecting devices
    • However, increase in inclination towards homecare self injecting devices for chronic patients and increasing advances to increase patient compliance threat of substitute remains low to medium

    Buyer Power

    • Bargaining power for medical device clients is medium to low as suppliers are constantly innovating to provide better patient compliance features